FDA clears Toshiba's coincidence option
The Food and Drug Administration cleared Toshiba America Medical Systems' coincidence detection imaging software for its Toshiba E. Cam last month, according to Lin Sinclair, product manager for the company's nuclear medicine division. Toshiba's E.Cams
The Food and Drug Administration cleared Toshiba America Medical Systems' coincidence detection imaging software for its Toshiba E. Cam last month, according to Lin Sinclair, product manager for the company's nuclear medicine division. Toshiba's E.Cams are supplied by Siemens Medical Systems, and the Hoffman Estates, IL, vendor obtained a 510(k) for its E.Cam coincidence package in October 1997. Toshiba of Tustin, CA, was required to apply for its own clearance, however, because its version of E.Cam uses Sun Microsystems UltraSparc computers, rather than the Macintosh-based Icon computers employed in Siemens E.Cams.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
